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License 4.0 (CC BY-NC).Mechanistic basis for the recognition of laminin-511 by
a6b1 integrin
Mamoru Takizawa,1* Takao Arimori,2* Yukimasa Taniguchi,1* Yu Kitago,2 Erika Yamashita,1
Junichi Takagi,2 Kiyotoshi Sekiguchi1†
Laminins regulate diverse cellular functions through interaction with integrins. Two regions of laminins—three
laminin globular domains of the a chain (LG1–3) and the carboxyl-terminal tail of the g chain (g-tail)—are re-
quired for integrin binding, but it remains unclear how the g-tail contributes to the binding. We determined the
crystal structure of the integrin binding fragment of laminin-511, showing that the g-tail extends to the bottom
face of LG1–3. Electron microscopic imaging combined with biochemical analyses showed that integrin binds to
the bottom face of LG1–3 with the g1-tail apposed to the metal ion–dependent adhesion site (MIDAS) of integrin b1.










Adhesion of cells to the basement membrane (BM) is a fundamental
biological process essential for tissue development and maintenance.
Laminins make a major contribution to the cell-adhesive activity of
the BMand elicit a variety of cellular responses through interactionwith
a panel of cell surface receptors, including integrins. Laminins consist of
three chains, a, b, and g, which assemble into a cross-shaped heterotri-
mer. In mammals, 11 laminin chains (a1 to a5, b1 to b3, and g1 to g3)
and 16 combinations of these have been identified (1). Laminin-511
(LM511), an isoform consisting of chains a5, b1, and g1, is expressed
in the early embryonic stage andmaintains tissue homeostasis through-
out life (2). Integrins are heterodimeric membrane proteins composed
of noncovalently associated a and b subunits (3). Twenty-four integrins
have been identified in mammals; among these, a6b1 integrin exhibits
the highest binding affinity for the a5 chain–containing laminin iso-
forms LM511 and LM521 (4).
The integrin binding activity of laminin has beenmappedwithin the
“E8” segment, comprising the distal part of the coiled-coil domain and
three laminin globular domains (LG1–3) of thea chain (Fig. 1A,middle).
LG1–3, which are prerequisite for integrin binding (5–7), have been
proposed to adopt a “cloverleaf” configuration based on electronmicro-
scopic observations (8), although LG1–3 alone adopted an open
configuration when their structure was determined by x-ray crystallog-
raphy (9). LG1–3 alone have no significant integrin binding activity
(10), suggesting that b and/or g chains facilitate the cloverleaf assembly
of LG1–3 for integrin recognition.
Our previous results showed that the Glu residue at the third posi-
tion from the C terminus of the g chain is crucial for integrin binding
(11, 12). However, it remains to be determined whether this Glu residue
in the C-terminal region of the g chain (designated the g-tail)
contributes to adopting an active LG1–3 conformation for integrin
recognition or directly interacts with integrins by coordinating the
metal ion held in the major ligand-binding site of integrins. This site
is referred to as theMIDAS (metal ion–dependent adhesion site). Here,
we sought to determine the role of the g-tail in the laminin-integrininteraction by x-ray crystallography combined with electron micro-
scopic imaging and a series of biochemical analyses.RESULTS
Crystal structure of the integrin binding region of LM511
Through a series of truncation/deletion mutagenesis experiments
coupled with evaluation of the integrin binding activity, we identified
a truncated LM511E8 (tLM511E8) suitable for the structural determi-
nation, which was successfully crystallized and whose structure was
determined at 1.8 Å resolution (fig. S1 and table S1). The structure of
tLM511E8 exhibited a “ladle” shape with LG1–3 adopting a compact
triangular cloverleaf configuration, where LG1 was in direct contact
with LG3 (Fig. 1, A and C). Each LG adopts a canonical b-sandwich
fold stabilized by a conserved disulfide bridge typical for this class of
domain. We found one calcium ion at the LG1-LG3 interface (Fig.
1B), where its octahedrally coordinating ligands were provided by both
LG1 (four ligands) and LG3 (one ligand), as well as one water molecule.
The overall arrangement of LG1–3 is in sharp contrast to that seen in
the same fragment of a2 chain previously reported in isolation, which
adopted an open configuration with LG1 completely dissociated from
LG3 (9). Thus, the cloverleaf assembly of LG1–3 in tLM511E8 should
have been brought about by the heterotrimeric assembly of the a5 chain
with a b1-g1 dimer, rather than by the direct contact between LG1 and
LG3 (Fig. 1D). Notably, LG1 and LG2 clamp the C-terminal region of
the b1-g1 dimer (Fig. 2A). LG1 contains a hydrophobic patch consisting
of residuesV2733, V2735, P2736, Y2913, F2915, L2921, and P2928 (Fig.
2B). Following the heterotrimeric assembly, the hydrophobic patch is
brought into direct contact with the side chains of Y1782 of the b1 chain
and L1596/P1597/F1601 of the g1 chain. As a result, LG1 is fastened to
the C-terminal region of the b1-g1 dimer through hydrophobic side-
chain interactions (Fig. 2C). LG2 faces the b1 chain pillar from the
opposite side, but there are no obvious side-chain interactions at the
interface. Instead, water molecules fill the gap by forming a hydrogen-
bonded network and secure the contacts of LG2 with the b1-g1 dimer
(Fig. 2D). Thus, heterotrimeric assembly may impose conformational
restriction on LG1 and LG2 to appose the b1 chain pillar and lead to
the cloverleaf assembly of LG1–3.
It has been proposed that theGlu residue in the g-tail associates with
LG1–3 to ensure their functional triangular assembly (5). However, the
five C-terminal residues of the g1 chain, including E1607 (g1E1607),1 of 8









which is the critical residue for integrin binding, are disordered in our
structure and have no direct contact with LG1–3 (Fig. 2 and fig. S2B),
strongly arguing against its role in stabilizing the functionally active
conformation of LG1–3. Recently, Pulido et al. (13) reported a high-
resolution crystal structure of the integrin binding region of mouse
LM111. The global structure of LM111 is essentially the same as that of
LM511 shown here, with both LM111 and LM511 exhibiting a triangular
configuration of LG1–3 with the b1-g1 dimer clamped between LG1 and
LG2. One interesting difference is that the LG3 in LM111 is positioned to
make the transverse plane of LG1–3orthogonal to the coiled-coil domain,
whereas LG3 in LM511 forms a beveled plane of LG1–3 (fig. S2A).
Nevertheless, the g1-tail in the LM111 structure is oriented toward the
bottom face of LG1/LG2 with the side chain of E1605 (equivalent to
g1E1607 in human) and the following residues disordered in the crystal
structure (fig. S2B), as in our human tLM511E8 structure.
LM511 binds to a6b1 integrin in a bottom-to-head manner
The ligand-binding site of integrins has been mapped to the upper
face of the integrin’s headpiece that consists of the b-propeller do-Takizawa et al., Sci. Adv. 2017;3 : e1701497 1 September 2017main of the a subunit and the bI/hybrid domains of the b subunit
(3). It is generally accepted that recognition of physiological ligands
by integrins relies on an acidic residue in the ligands, coordinating
a divalent metal ion in the MIDAS of the integrin b subunit (b-MIDAS)
(14). Consistent with this scheme, the Glu residues in the g1-tail
(E1607) and g2-tail (E1191) are essential for integrin binding by lami-
nins; the g3 chain does not have an equivalent Glu residue (11, 12).
Furthermore, our exhaustive survey demonstrated that no single acidic
residue in the LM511E8 fragment other than g1E1607 is critically re-
quired for integrin binding (15), pointing toward the possibility that
g1E1607 directly coordinates with the b-MIDAS. To gain insight into
the location of the integrin binding site within LM511, we examined
LM511E8 complexed with recombinant a6b1 integrin by electron mi-
croscopy. A gallery of electron microscopic images revealed that the
headpiece of a6b1 integrin always bound to LM511E8 at the site op-
posite the filament-like coiled-coil extension (Fig. 3A and fig. S3).
These results indicate that LM511 binds to a6b1 integrin via the
bottom face of LG1–3, where the disordered five C-terminal resi-
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Fig. 1. The integrin binding region of LM511. (A) Front (left) and lateral (right) faces of the integrin binding region of LM511 that consists of chains a5 (green),
b1 (blue), and g1 (red). LG1–3 of the a5 chain are colored in deep green (LG1), green-cyan (LG2), and yellow-green (LG3). A calcium ion at the LG1-LG3 interface is
shown as a magenta sphere, disulfide-linked Cys residues as yellow sticks, and Ca atoms of C-terminal residues as orange spheres. (B) Octahedral calcium coordination
in the LG1-LG3 interface. (C) Triangular cloverleaf configuration of LG1–3. (D) Schematic illustration of the configurational change of LG1–3 from “open” to “cloverleaf”
through coiled-coil assembly.2 of 8









The g1-tail is positioned close to the metal ion of
the b1-MIDAS
To further clarify the possibility that the g1-tail directly interacts with
a6b1 integrin, we simultaneously introduced Cys substitutions into the
g1-tail and the bI domain of integrin b1 and then performed exhaustive
screening for intermolecular disulfide formation between the Cys-
substituted LM511E8 and the a6b1 integrin. We reasoned that a
Cys residue introduced adjacent to g1E1607 would become cross-
linked to a Cys residue introduced near the b1-MIDAS if the g1-tail
directly interacts with integrin b1. Thus, we introduced Cys substi-
tutions of residues I1606 and K1608 of the g1-tail (Fig. 3C) and of
19 residues in the bI domain that are predicted to be surface-exposed
near the b1-MIDAS (fig. S4). LM511E8 with g1-I1606C and g1-
K1608C substitutions (designated LM511E8/I1606C and LM511E8/
K1608C, respectively) retained integrin binding activity, whereas those
having additional Gln substitutions for g1E1607 (designated LM511E8/
I1606C/EQ and LM511E8/K1608C/EQ) were almost devoid of the ac-
tivity (fig. S5). Coexpression of Cys-substituted LM511E8 and a6b1
integrin in mammalian cells and subsequent immunoprecipitation of
secreted LM511E8, followed by SDS–polyacrylamide gel electrophore-
sis (SDS-PAGE) under nonreducing conditions, identified a total of
seven disulfide-linked products between LM511E8 and a6b1 integrin,
depending on the position of the Cys substitution near the b1-MIDAS
(Fig. 3, D and E, and fig. S6). LM511E8/I1606C was disulfide-linked to
four Cys-substituted integrin b1 residues: 133, 221, 222, and 223
(Fig. 3E, top); LM511E8/K1608C was disulfide-linked to three Cys-
substituted residues: 133, 223, and 225 (Fig. 3E, bottom). The ability
of both laminin mutants to form disulfide bonds with integrin b1 resi-
dues 133 and 223 is consistent with the fact that these residues are
closest to the MIDAS metal ion, where g1E1607 is predicted to ligate
(Fig. 3D). In contrast, residues 221 and 222, which are located further
away from the a subunit, preferentially cross-linked to LM511E8/
I1606C,whereas residue 225, situated closer to thea subunit, efficientlyTakizawa et al., Sci. Adv. 2017;3 : e1701497 1 September 2017cross-linked to LM511E8/K1608C. These results suggest that the
I1606-E1607-K1608 segment of the g1-tail is aligned parallel to the seg-
ment with residues 221 to 225 of the a2-a3 loop of integrin b1, with the
C-terminal end of the former pointing toward the b-propeller domain
of integrina6when g1E1607 coordinateswith the b1-MIDASmetal ion
(Fig. 3F, top). This is in sharp contrast to the common mode of Arg-
Gly-Asp (RGD) motif recognition by many integrins, where a short
peptide segment is docked at the a-b interface in the N→C direction,
with the side chains of Arg and Asp being recognized by the a and b
subunits of integrins, respectively (Fig. 3F, bottom) (16–18).
To confirm the specificity of the intermolecular disulfide formation
between the Cys-substituted LM511E8 and the a6b1 integrin, we per-
formed the disulfide cross-link assays using laminin mutants carrying
the inactivatingGlnmutation at g1E1607 (fig. S7). TheGln substitution
resulted in a significant reduction in the disulfide formation, suggesting
that efficient disulfide bond formation requires correct steering of the
g1-tail guided by the g1E1607-MIDAS interaction. It is also notable
that intermolecular disulfide bonds, particularly involving integrin
b1 residue 133, form to some extent in the absence of g1E1607, suggest-
ing that LM511E8 devoid of g1E1607 has weak but appreciable binding
ability to integrin.
g1-Tail–derived peptide inhibits laminin-integrin interaction
Although these results strongly support the idea that the g1-tail com-
prises the integrin binding site of LM511 and directly interacts with the
b1-MIDAS of a6b1 integrin, we have been unable to show competitive
inhibition of integrin-ligand interaction using synthetic peptides
derived from the g1-tail (11), which has been repeatedly observed in
RGD-recognizing integrins with RGD and related peptides (19). To re-
visit the effect of synthetic g1-tail peptides on laminin-integrin inter-
actions, we performed inhibition assays using a g1-tail–derived
pentapeptide SIEKP (designated g1C5) and its E-to-Qmutant (SIQKP)
under conditions where a6b1 integrin was rendered conformationallyFig. 2. Association of LG1–3 with b1-g1 dimer. (A) Back view showing LG1-LG2 (surfaces), b1-g1 dimer (ribbons) with side chains (sticks), and water molecules (spheres).
(B) Hydrophobic patch on LG1. (C) Hydrophobic interactions between the hydrophobic patch of LG1 and the C-terminal region of the b1-g1 dimer. (D) The interaction
between LG2 and b1 chain was mediated by a layer of hydrogen-bonded water molecules. 2Fo-Fc electron density map countered at 1.0s is shown as blue mesh around
water molecules.3 of 8









active by the activating anti-integrin b1 antibodyTS2/16. g1C5was only
weakly inhibitory to a6b1 integrin binding to LM511E8 in the absence
of TS2/16, but it exerted a significant inhibitory activity in the presence
of TS2/16 [half-maximal inhibitory concentration (IC50) approximately
25 mM] (Fig. 4A). The inhibitory activity of g1C5 was abrogated by the
E-to-Q substitution, lending support to the idea of direct interaction of
the g1-tail with a6b1 integrin in a g1E1607-dependent manner.DISCUSSION
Despite the requirement for the Glu residue within the g-tail in integrin
recognition by laminins, it has remained unsettled whether the g-tail isTakizawa et al., Sci. Adv. 2017;3 : e1701497 1 September 2017required for the maintenance of a functionally active conformation of
LG1–3 of the a chain or whether it directly interacts with integrin by
coordinating the metal ion in the b-MIDAS. Several lines of evidence
obtained in this study support the latter possibility. First, the g1-tail of
tLM511E8 was found disordered in the crystallized structure and there-
fore does not seem to contribute significantly to the maintenance of
LG1–3 conformation. The C-terminal region of the b1-g1 dimer is
clamped between LG1 and LG2, suggesting that the disordered g1-tail
extends to the bottom face of the ladle-shaped tLM511E8. Second, elec-
tron microscopic imaging of LM511E8 complexed with a6b1 integrin
revealed that LM511E8 binds to the integrin in a bottom-to-head

















































































Fig. 3. Close contact of the g1-tail with the headpiece of a6b1 integrin. (A) Electron microscopic image of LM511E8 complexed with a6b1 integrin (see also fig. S3).
(B) Schematic illustration of the interaction between LM511E8 and a6b1 integrin. (C) Amino acid sequences of wild-type (WT) and Cys-substituted g1-tails. Cys-
substituted residues are shown in yellow. (D) The residues cross-linked to the g1-tail (yellow sticks) lie near the metal ion (green sphere) in the MIDAS site of integrin
b1 (b1-MIDAS) (Protein Data Bank ID: 4WJK). The b1-MIDAS metal ion and water molecules are depicted as green and red spheres, respectively. (E) Intermolecular
disulfide formation between LM511E8 having g1-I1606C (top) or g1-K1608C (bottom) substitution and Cys-substituted a6b1 integrins (see also fig. S6). Arrowheads
indicate disulfide-linked products. (F) Distinct topologies of the g-tail (top) and the RGD motif (bottom) on the integrin’s headpiece.4 of 8









lies at the bottom face of LG1–3. Third, intermolecular disulfide cross-
link screening with a panel of Cys-substituted LM511E8s and a6b1
integrins demonstrated that the g1-tail is selectively disulfide-linked
to residues near the b1-MIDAS, supporting the idea of direct interaction
of the g1-tailwith integrin’s b1-MIDAS. Finally, the g1C5peptide SIEKP
inhibited the binding of LM511E8 to a6b1 integrin, but its E-to-Qmu-
tant did not, corroborating the direct interaction of the g1-tail witha6b1
integrin, in which g1E1607 is prerequisite. Together, these findings lead
us to conclude that the g1-tail directly interactswith integrin’sb1-MIDAS,
with g1E1607 serving as the critical acidic residue that coordinates
the metal ion in the b1-MIDAS.
There is compelling evidence that LG1–3 is required for laminin
recognition by integrins. Deletion of LG1–3 or substitution of any one
of the LGs nullifies the integrin binding activity of laminins (10, 20).
Furthermore, the integrin binding specificity, as well as the affinity of
laminin isoforms, has been shown to be primarily defined by the laminin
a chains (4). In support of the involvement of LG1–3 in laminin recog-
nition by integrins, the LM511E8 mutant lacking the five C-terminal
residues of the g1-tail competitively inhibited thebinding ofa6b1 integrin
to LM511E8, albeit at a much higher concentration than intact E8
(fig. S8). Given that LM511E8 binds to a6b1 integrin in a bottom-to-
head manner, it is conceivable that LG1–3 harbor an auxiliary integrin
recognition site(s) at their bottom face that can complement the
primary site involving the g1-tail, although the detailed location of this
site(s) remains to be explored. Pulido et al. (13) noted that the LG1 andTakizawa et al., Sci. Adv. 2017;3 : e1701497 1 September 2017LG2 surfaces on either side of the g1-tail aremore highly conserved than
that of LG3, implying that the residues involved in integrin binding lie
within the highly conserved surfaces. Our exhaustive disulfide cross-
link screening with Cys-substituted LM511E8 and a6b1 integrin
showed that the g1-tail came into close contact with and cross-linked
with integrin b1 residue 133 near the b1-MIDAS even in the absence of
g1E1607. These findings suggest that the interaction of a6b1 integrin
with the bottom face of LG1–3 brings the g1-tail into close contact with
theb1-MIDAS, thereby stabilizing the laminin-integrin complex (Fig. 4B).
In conclusion, we report evidence that supports a scheme in which
the g1-tail directly interacts with integrin b1, with g1E1607 coordinat-
ing the metal ion in the b1-MIDAS during formation of the LM511–a
6b1 integrin complex.These findings contribute to abetter understanding
of the molecular basis of laminin-integrin interactions in diverse aspects
of cellular function.MATERIALS AND METHODS
Antibodies and reagents
Horseradish peroxidase (HRP)–conjugated mouse anti-5×His mAb
was from Qiagen. Monoclonal ANTI-FLAG M2 antibody was pur-
chased from Sigma-Aldrich. HRP-conjugated mouse anti–c-Myc
mAb (clone 9E10) was purchased from Abcam. Rabbit polyclonal
antibody (pAb) against the ACID/BASE coiled-coil region (designated














































































Fig. 4. Direct contribution of g1E1607 to laminin-integrin interaction. (A) Inhibition of the LM511E8–a6b1 integrin interaction by g1-tail–derived peptides [white,
g1C5; black, g1C5(EQ)] in the absence (circle) or presence (square) of the integrin b1 activating monoclonal antibody (mAb) TS2/16. IC50 values of peptides (means ± SD
of three independent experiments) are shown in the table (right). (B) Schematic model for the mechanism by which integrin recognizes laminin.5 of 8









peptides, as described previously (21). The anti-Velcro pAb was bio-
tinylated using EZ-Link Sulfo-NHS-Biotin reagents (Thermo Fisher
Scientific) according to the manufacturer’s instructions. mAb 5D6
against the human laminin a5 chain was generated in our laboratory,
as described previously (22).mAb4C7 against the LGof human laminin
a5 chain (10, 23, 24) was from Merck Millipore. Mouse immuno-
globulin G (IgG) was from Thermo Fisher Scientific. HRP-conjugated
goat anti-mouse IgGpAbwaspurchased from Jackson ImmunoResearch.
HRP-conjugated streptavidin was from Thermo Fisher Scientific. The
mAb TS2/16 against human integrin b1 was purified on a Protein G
Sepharose 4 Fast Flow column (GE Healthcare) from the conditioned
media of hybridoma cells obtained from the American Type Culture
Collection. Restriction enzymesNhe I, BamHI, andNot Iwere obtained
from New England BioLabs. AcTEV protease, which is an enhanced
formof tobacco etch virus (TEV) protease, was purchased fromThermo
Fisher Scientific. Synthetic peptides derived from the five C-terminal
residues of the human laminin g1 chain, namely, g1C5 and g1C5
(EQ), were purchased from Greiner Bio-One.
Construction of expression vectors
Expression vectors for recombinant E8 fragments of human laminina5,
b1, g1, and g1 having a Gln substitution for g1E1607 were prepared as
described (11). 6×His, hemagglutinin (HA), and FLAG tags were added
to the N termini of LMa5E8, LMb1E8, and LMg1E8, respectively. An
expression vector for LMa5E8 inwhich the 6×His tagwas replacedwith
a c-Myc tag was generated by extension polymerase chain reaction
(PCR) using 6×His tag–conjugated LMa5E8 expression vector as the
template. Expression vectors for LMg1E8/I1606C, LMg1E8/I1606C/
EQ, LMg1E8/K1608C, and LMg1E8/K1608C/EQ were generated by
extension PCR, using LMg1E8 and LMg1E8/EQ expression vectors
as templates. The pcDNA3.4+MCS vector was generated by inserting
the multiple cloning site sequence derived from the expression vector
pSecTag2A into the TOPO cloning site of pcDNA3.4-TOPO (Thermo
Fisher Scientific).
Expression vectors for individual truncated-E8 fragments of human
laminin a5, b1, and g1 chains (designated tLMa5E8, tLMb1E8, and
tLMg1E8, respectively) were constructed as follows. Complementary
DNAs encoding tLMa5E8 (E2655–A3327), tLMb1E8 (D1714–L1786),
and tLMg1E8 (D1528–P1609) were amplified by PCR using individual
E8 expression vectors as templates. The PCR products were digested
with Nhe I and Not I and then ligated into the Nhe I–Not I sites, that
is, between the Nhe site and the Not I site, of pcDNA3.4+MCS. 6×His,
HA, and FLAG tags, followed by a TEV protease recognition sequence,
were added by extension PCR. The PCR products were digested with
Nhe I/Not I and inserted into the corresponding restriction sites of
pcDNA3.4+MCS. tLMa5E8/I2723C and tLMg1E8/D1585C mutants
were generated by extension PCR using tLMa5E8 and tLMg1E8 ex-
pression vectors as templates, respectively. The PCR products were
digested with Nhe I/Not I and inserted into the corresponding restric-
tion sites of pcDNA3.4+MCS.
An expression vector for the extracellular domain of human integrin
a6 with C-terminal ACID peptide and FLAG tag sequences was
prepared as described previously (10). An expression vector for the ex-
tracellular domain of human integrin b1 with a BASE peptide and a
6×His tag sequence at the C terminus was prepared as described previ-
ously (21). Expression vectors for integrin b1 mutants, in which 19 res-
idues located on the I-like domain were individually Cys-substituted,
were produced by extension PCR, using integrin b1 expression vector
as the template. The PCR products were digested with Bam HI/Not ITakizawa et al., Sci. Adv. 2017;3 : e1701497 1 September 2017and cloned into the same sites of the wild-type construct. All DNA
sequences were verified using ABI PRISM 3130xl Genetic Analyzer
(Thermo Fisher Scientific).
Expression and purification of recombinant proteins
LM511E8 was transiently expressed in FreeStyle 293-F cells (Thermo
Fisher Scientific) according to the manufacturer’s instructions.
Conditioned media were collected 72 hours after transfection and
loaded onto cOmplete His-Tag Purification Resin (Roche). The resin
was washed with Hepes-buffered saline (HBS) (8.0) [20 mM Hepes
and 137 mM NaCl (pH 8.0)], and the protein was eluted with HBS
(8.0) containing 250 mM imidazole. Fractions containing LM511E8
were further loaded onto DDDDK-tagged Protein Purification Gel
(MBL). The resin was washed with HBS (7.4) [20 mM Hepes and
137 mM NaCl (pH 7.4)], and the proteins were eluted with HBS
(7.4) containing DDDDK peptide (100 mg/ml; MBL). Fractions
containing LM511E8 were concentrated with Amicon Ultra-15 (Merck
Millipore) and further purified on a Superdex 200 10/300 GL column
(GE Healthcare) using HBS (7.4) as the running buffer.
tLM511E8 for crystallization was produced using FreeStyle 293-F
cells and purified by affinity chromatography as for LM511E8.
Fractions containing tLM511E8 were concentrated using Amicon
Ultra-15 and digested with TEV protease (2000 U/ml) at 25°C for
24 hours. The reaction mixture was subjected to gel filtration on a
Superdex 200 10/300 GL column using HBS (7.4) as the running
buffer. Fractions containing TEV-digested tLM511E8 were concen-
trated with Amicon Ultra-2 (Merck Millipore) to ~30 mg/ml and
stored at −80°C.
Recombinant human a6b1 integrin was prepared as described pre-
viously (10, 11). Intact a6b1 integrin for electron microscopic observa-
tion was prepared using the same expression system. The conditioned
mediawere loaded ontoANTI-FLAGM2AffinityGel (Sigma-Aldrich),
and bound proteins were eluted with HBS (7.4) containing FLAG pep-
tide (100mg/ml). Fractions containinga6b1 integrinwere concentrated
with Amicon Ultra-4 (Merck Millipore) and immediately subjected to
gel filtration on a Superdex 200 10/300 GL column using HBS (7.4) as
the running buffer. Fractions containing a6b1 integrin were collected
and stored at−80°C. Protein concentrations of all recombinant products
were determined using Pierce BCA Protein Assay Kit (Thermo Fisher
Scientific) using bovine serum albumin (BSA) as the standard.
Solid-phase integrin binding assay
Binding activities of a6b1 integrin to wild-type andmutant LM511E8s,
including tLM511E8, were measured by solid-phase binding assays as
follows. LM511E8swere adsorbedonto 96-wellmicrotiter plates (Thermo
Fisher Scientific) at 10 nM overnight at 4°C and then blocked with
3% BSA at room temperature for 1 hour. The amounts of LM511E8s
adsorbed on the plates were quantified with mAbs 5D6 and 4C7 to
confirm the equality of the amounts of adsorbed proteins. After
washing once with tris-buffered saline (TBS) [20 mM tris and 137 mM
NaCl (pH 7.4)] containing 1 mMMnCl2, 0.3% BSA, and 0.02% Tween
20 (Mn2+ buffer), the plates were incubated with serially diluted a6b1
integrin solution at room temperature for 3 hours in the presence of
1 mM MnCl2 or 10 mM EDTA. After three washes with Mn
2+ buffer
or TBS containing 10 mM EDTA, 0.3% BSA, and 0.02% Tween 20, the
plateswere incubatedwith biotinylated rabbit anti-VelcropAb (1.5mg/ml)
in Mn2+ buffer at room temperature for 30 min. After three washes with
Mn2+buffer, theplateswere incubatedwith streptavidin-HRP(0.53mg/ml)
for 15 min. After three washes with Mn2+ buffer, the amount of bound6 of 8









a6b1 integrin was quantified by measuring the absorbance at 490 nm
after incubation with o-phenylenediamine. The apparent dissociation
constants were determined as described previously (25).
Preparation of laminin-integrin complex
The laminin-integrin complex was formed bymixing 200 pmol of puri-
fied LM511E8 and the same amount of purified a6b1 integrin at room
temperature for 30 min in HBS (7.4) containing 1 mM MnCl2. The
complex was subjected to gel filtration on a Superose 6 10/300 GL col-
umn (GE Healthcare) preequilibrated with HBS containing 1 mM
MnCl2. Fractions containing the complex were identified by SDS-
PAGE followed by Coomassie Brilliant Blue staining.
Electron microscopy and image processing
The fractionated complex was incubated for 1 min at room tem-
perature on glow-discharged carbon-coated grids (Nisshin EM).
Samples were washed three times in ultrapure water containing
1 mM MnCl2 and stained three times with 2% uranyl acetate for
30 s. After vacuum drying, grids were inspected with a Hitachi H-7650
transmission electron microscope operated at 80 kV.
Intermolecular disulfide bond formation between LM511E8
and a6b1 integrin
c-Myc–tagged LMa5E8 was used throughout the intermolecular
disulfide formation assays. LM511E8/wild type, LM511E8/I1606C,
LM511E8/I1606C/EQ, LM511E8/K1608C, and LM511E8/K1608C/
EQ were transiently coexpressed with wild-type or Cys-introduced
a6b1 integrin using the FreeStyle 293 Expression System. Seventy-
two hours after transfection, conditioned media were incubated with
mAb 5D6 (1 mg/ml) at 4°C for 1 hour. Secreted laminin-integrin
complexes were precipitated with Protein G Sepharose 4 Fast Flow
(GE Healthcare). Immunoprecipitates were analyzed by SDS-PAGE
under nonreducing conditions, followed by immunoblotting with
anti–c-Myc mAb and anti-Velcro pAb.
Inhibition of a6b1 integrin binding to LM511E8
Wild-typeLM511E8was adsorbedonto96-wellmicrotiterplates at 10nM
overnight at 4°C and then blocked with 3% BSA at room temperature
for 1 hour. Serially diluted synthetic peptide [g1C5 or g1C5(EQ)] or
LM511E8 (wild type orDg1C5) was incubated with 1 nM a6b1 integrin
inMn2+ buffer containing 3 nM isotype control IgG or integrin b1 ac-
tivating mAb TS2/16 at room temperature for 1 hour, then added to
LM511E8-coated plates, and allowed to bind to LM511E8 at room
temperature for 1 hour. After three washes with Mn2+ buffer, the
plates were incubated with biotinylated rabbit anti-Velcro pAb
(1.5 mg/ml) inMn2+ buffer at room temperature for 30min. After three
washes with Mn2+ buffer, the plates were incubated with streptavidin-
HRP (0.53 mg/ml) for 15 min. After three washes with Mn2+ buffer, the
amount of bound a6b1 integrin was quantified by measuring the
absorbance at 490 nm after incubation with o-phenylenediamine.
IC50 values were calculated using the following equation
y ¼ A D
1þ ðx=CÞB þ D
where x is peptide or LM511E8 concentration (in micromolars per
nanomolar), “y” is activity (in percent) in the presence of inhibitors
relative to the activity in the absence of inhibitors, “A” correspondsTakizawa et al., Sci. Adv. 2017;3 : e1701497 1 September 2017to the relative activity on the top plateau region of the curve, “B” cor-
responds to the slope, “C” corresponds to the inflection point of the
curve, and “D” corresponds to the relative activity on the bottomplateau
region of the curve. To obtain these four parameters, experimental raw
data points were fitted to this equation using the “Curve Fitter” tool of
ImageJ software (26). IC50 values were determined by substituting “y =
50” in the abovementioned equation.
Crystallization and diffraction data collection
Crystallization was performed at 20°C. Initial screening of crystal-
lization conditions was performed using The Classics Neo Suite
(Qiagen). For this screen, a mosquito crystallization robot (TTP
LabTech) was used to dispense 0.5 ml of protein solution mixed
in a 1:1 ratio with the reservoir solution. Drops were equilibrated
over 80 ml of reservoir solution using the sitting drop vapor diffusion
method. The initial crystallization condition [0.2M ammonium sulfate,
0.1 M sodium acetate (pH 4.6), and 25% polyethylene glycol 4000 at
room temperature] was optimized using a 24-well crystallization plate
with the hanging drop vapor diffusion method. Each well contained
500 ml of reservoir solution, and the drop volumewas amixture of 0.5 ml
of protein solution and 0.5 ml of reservoir solution. Diffraction quality
crystals were obtained under conditions of 0.2 M ammonium sulfate,
0.1M sodium acetate adjusted to pH 4.2with acetic acid, and 19%poly-
ethylene glycol 4000. Before x-ray diffraction experiments, crystals were
soaked in reservoir solution containing an additional 20% glycerol and
flash-cooled in liquid nitrogen.
The diffraction data set for phasing was collected at BL-1A, Photon
Factory (Tsukuba, Japan), and processed using the XDS package (27).
In this data collection, three data sets of 720° each with an oscillation
angle of 0.2° were merged. A higher-resolution data set for refinement
was collected at BL44XU, SPring-8 (Hyogo, Japan), and processed using
the HKL2000 package (28). The diffraction data statistics are shown in
table S1.
Structure determination
The crystal structure of tLM511E8 was solved by the single-
wavelength anomalous dispersion method using native crystals.
The coordinates of the substructure including the sulfur atoms
and the calcium ion were determined using SHELXC and SHELXD
(29). The phase calculation using these coordinates with phase im-
provement followed by automated initial model building was per-
formed using the PHENIX program package (30). This initial
model was then extended and refined by manual editing using
COOT (31), with the iterated implementation of refmac5 (32) on
the higher-resolution data set. Finally, the crystal structure was re-
fined to the R/Rfree factors of 0.202/0.237 at a resolution of 1.80 Å,
validated with MOLPROBIDY (33). Refinement statistics are de-
scribed in table S1. All figures of the tLM511E8 model in this article
were produced using PyMOL (www.pymol.org/).SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/9/e1701497/DC1
fig. S1. Preparation and crystallization of tLM511E8.
fig. S2. Comparison of the crystal structures of tLM511E8 and mini-E8 of LM111.
fig. S3. Electron microscopic imaging of the LM511E8–a6b1 integrin complex.
fig. S4. Cys-substituted residues on bI domain.
fig. S5. Integrin binding activity of wild-type and Cys-substituted LM511E8s.
fig. S6. Disulfide formation between Cys-substituted LM511E8 and a6b1 integrin.7 of 8
SC I ENCE ADVANCES | R E S EARCH ART I C L Efig. S7. Disulfide cross-link assays using LM511E8/I1606C/EQ and LM511E8/K1608C/EQ.
fig. S8. Inhibition of the LM511E8–a6b1 integrin interaction by wild-type and Dg1C5 LM511E8.
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